Women Health Diagnostics Market
According to Intent Market Research, the Women Health Diagnostics Market is expected to grow from USD 9.4 billion in 2023 at a CAGR of 12.4% to touch USD 21.3 billion by 2030. The Women Health Diagnostics Market is dominated by key players such as Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Hologic, Inc., Thermo Fisher Scientific, Danaher Corporation, Quest Diagnostics, Becton Dickinson and Company, Labcorp Diagnostics, Bio-Rad Laboratories, PerkinElmer, Inc., Cepheid (Danaher Corporation) and Ortho Clinical Diagnostics.